Healthy Skepticism Library item: 10097
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: media release
State of the Clinical Trials Industry 2007 Sourcebook Charts Drug Pipeline Trends Affecting Healthcare Industry
Thomson Healthcare 2007 May 2
http://www.thomson.com/content/pr/tsh/201076
Full text:
Thomson Healthcare compendium tracks growth of clinical research outsourcing, rates top clinical trial sponsors and analyzes industry-wide spending data
BOSTON, Mass., May 2, 2007 – Russia is on track to become the next big clinical research market; global pharma R&D spending is projected to top $100 billion in 2007; and convenience is the number one concern of patients participating in clinical trials. These are just three of the hundreds of data points and research observations featured in State of the Clinical Trials Industry 2007, an annual sourcebook produced by Thomson CenterWatch, a leading provider of information and solutions to the clinical trials industry, and a business within of The Thomson Corporation (NYSE: TOC; TSX: TOC).
State of the Clinical Trials Industry 2007 is a comprehensive resource that examines all aspects of the clinical trials industry, providing original CenterWatch data gleaned from in-depth industry analyses, physician and patient surveys and report-card-style ratings of pharmaceutical sponsors and clinical researchers. Data highlights included in the 400-plus page book include:
Causes and costs associated with study delays;
Trial success based on company size;
Clinical Research Organization (CRO) market size, costs and performance;
Investigative site perceptions of sponsors and CROs within the US, Europe, and Latin America;
Worldwide sales (within the pharmaceutical, medical device, and biotech sectors);
Overall R&D spending and cycle times;
Regulatory submissions and approvals within the US and internationally.
“The most compelling observations in this year’s edition of State of the Clinical Trials Industry focus on the significant challenges pharmaceutical companies have faced with clinical trial recruitment,” notes Mary Jo Lamberti, senior manager of Market Research for Thomson CenterWatch. “To manage these challenges, companies are looking outside the U.S., particularly toward Asia, Latin America, and more recently, to Russia, to conduct clinical trials,” she said. “State of the Clinical Trials Industry provides insights to these and other trends, and helps clinical researchers, biotech and pharmaceutical executives, CRO executives and investment analysts track and react to changes in the industry.”
State of the Clinical Trials Industry 2007 contains over 500 charts, graphs, and tables; a review of the top clinical research stories of 2006 as reported by the editorial staff of The CenterWatch Monthly; as well as drug pipeline information and updates on specific disease areas. Much of the data is based on CenterWatch’s clinical research benchmarking surveys that have been conducted across global segments and represents an analysis of current sponsor and CRO practices. The 2007 edition features more than 100 completely new charts analyzing the clinical research industry along with hundreds more updated slides from our 2006 edition.
About Thomson Healthcare
Thomson Healthcare is the leading provider of decision support solutions that help organizations across the healthcare industry improve clinical and business performance. Thomson Healthcare products and services help clinicians, hospitals, employers, health plans, government agencies, and pharmaceutical companies understand healthcare markets, access medical and drug information, manage costs, and improve the quality of healthcare.
Thomson Healthcare is a part of The Thomson Corporation, a provider of value-added information, software tools and applications to professionals in the fields of healthcare, law, tax, accounting, scientific research, and financial services. The Corporation’s common shares are listed on the New York and Toronto stock exchanges (NYSE: TOC; TSX: TOC). For more information, visit www.thomsonhealthcare.com.
